Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases

AIM: To assess the impact of preoperative neoadjuvant bevacizumab (Bev) on the outcome of patients undergoing resection for colorectal liver metastases (CLM). METHODS: Eligible trials were identified from Medline, Embase, Ovid, and the Cochrane database. The data were analyzed with fixed-effects or...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Li, De-Bang, Ye, Feng, Wu, Xiu-Rong, Wu, Lu-Peng, Chen, Jing-Xi, Li, Bin, Zhou, Yan-Ming
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2013
Konular:
Meta-Analysis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574604/
https://ncbi.nlm.nih.gov/pubmed/23431050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i5.761
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller